Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Don't Blame Me, I Voted For Kerry -- Ignore unavailable to you. Want to Upgrade?

To: Amy J who wrote (53723)	10/20/2004 9:20:54 AM
From: jttmab	Respond to of 81568

In 1990 the NIH issued guidelines requiring the inclusion of women and minorities in all NIH funded clinical research to address the issue of gender/minority inequities in medical research and funding. Unfortunately, the problem is that the guidelines were basically ignored. I'm not sure that I'd go as far as "law". If the research is privately funded, I don't think it's possible [or reasonable] to require how private funds are to be spent. If it's federally funded, you run into a problem with "not enough money to go around." And I don't think there's going to be any separate male and female studies for prostate and breast cancer. Not in disagreement with your point, but I recall seeing a report that there wasn't the greatest correlation between cause of death/incidence and research funds allocated to begin with, let alone trying to reconcile that by sex. In a world of limited funds, there is bound to be unfairness depending on how you cut the statistics. But thank you for bringing it to my attention. I learned quite a bit because of it. Galloping around the net, I found this URL that would be handy for you to have. It mentions some of your specific points and broadens it. womentowomen.com jttmab